Aptus Capital Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
3,532
-399
-10% -$26.2K ﹤0.01% 1070
2026
Q1
$280K Sell
3,931
-2,368
-38% -$187K ﹤0.01% 902
2025
Q4
$517K Buy
6,299
+163
+3% +$12.7K ﹤0.01% 718
2025
Q3
$461K Sell
6,136
-4,082
-40% -$304K ﹤0.01% 712
2025
Q2
$757K Buy
10,218
+5,213
+104% +$363K 0.01% 589
2025
Q1
$404K Buy
5,005
+242
+5% +$20.8K ﹤0.01% 705
2024
Q4
$372K Buy
4,763
+558
+13% +$47.4K ﹤0.01% 718
2024
Q3
$395K Buy
4,205
+622
+17% +$52.2K 0.01% 600
2024
Q2
$279K Buy
3,583
+92
+3% +$7.5K ﹤0.01% 637
2024
Q1
$317K Buy
+3,491
New +$290K 0.01% 617

Other funds holding GEHC

Aptus Capital Advisors's GEHC Position: Q2 2026 in Review

Aptus Capital Advisors reduced its GE HealthCare (GEHC) stake by 10% in Q2 2026, selling an estimated $26.2K and leaving 3,532 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Aptus Capital Advisors first reported a position in GEHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $757K in Q2 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Aptus Capital Advisors held 3,532 shares of GE HealthCare worth $226K as of Q2 2026.
  • Aptus Capital Advisors sold 399 GE HealthCare shares in Q2 2026, an estimated $26.2K.
  • GE HealthCare made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1070 holding.
  • Aptus Capital Advisors first reported a position in GE HealthCare in Q1 2024 and has held it in 10 quarters since.
  • Aptus Capital Advisors's GE HealthCare position peaked at $757K in Q2 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.